Bruno Mégarbane

ORCID: 0000-0002-2522-2764
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Poisoning and overdose treatments
  • Cardiac Arrest and Resuscitation
  • Forensic Toxicology and Drug Analysis
  • Drug-Induced Hepatotoxicity and Protection
  • COVID-19 Clinical Research Studies
  • Opioid Use Disorder Treatment
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Mechanical Circulatory Support Devices
  • Respiratory Support and Mechanisms
  • Pharmacological Effects and Toxicity Studies
  • Alcoholism and Thiamine Deficiency
  • Pneumonia and Respiratory Infections
  • Cannabis and Cannabinoid Research
  • Epilepsy research and treatment
  • Thermal Regulation in Medicine
  • Pesticide Exposure and Toxicity
  • Cardiac electrophysiology and arrhythmias
  • Long-Term Effects of COVID-19
  • Antibiotics Pharmacokinetics and Efficacy
  • Veterinary Pharmacology and Anesthesia
  • Nosocomial Infections in ICU
  • SARS-CoV-2 and COVID-19 Research
  • Neurotransmitter Receptor Influence on Behavior
  • Anesthesia and Sedative Agents

Assistance Publique – Hôpitaux de Paris
2016-2025

Inserm
2016-2025

Université Paris Cité
2016-2025

Hôpital Lariboisière
2016-2025

Optimisation Thérapeutique en Neuropsychopharmacologie
2012-2024

Sorbonne Paris Cité
2012-2024

Hôpital Fernand-Widal
2014-2024

Hypertension pulmonaire : physiopathologie et innovation thérapeutique
2018-2023

Mère et Enfant en Milieu Tropical
2023

Générale de Santé
2022-2023

The Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation patients with septic shock. However, whether this blood-pressure target is more or less effective than higher unknown.In multicenter, open-label trial, we randomly assigned 776 shock to undergo either 80 85 (high-target group) 70 (low-target group). primary end point was mortality day 28.At 28 days, there no significant between-group difference in mortality, deaths...

10.1056/nejmoa1312173 article EN New England Journal of Medicine 2014-03-18
Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10

<h3>Context</h3>Based on concerns about the risk of infection, jugular site is often preferred over femoral for short-term dialysis vascular access.<h3>Objective</h3>To determine whether catheterization decreases nosocomial complications compared with catheterization.<h3>Design, Setting, and Patients</h3>A concealed, randomized, multicenter, evaluator-blinded, parallel-group trial (the Cathedia Study) 750 patients from a network 9 tertiary care university medical centers 3 general hospitals...

10.1001/jama.299.20.2413 article EN JAMA 2008-05-28

Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired is low. We aimed to determine relationship between pneumonia, as compared influenza pneumonia or no viral infection, and VA-LRTI.Multicenter retrospective European cohort performed in 36 ICUs. All adult receiving invasive mechanical ventilation > 48 h were eligible if they had: at ICU admission. VA-LRTI,...

10.1007/s00134-020-06323-9 article EN other-oa Intensive Care Medicine 2021-01-02

Rationale: Frontline healthcare providers (HCPs) during the coronavirus disease (COVID-19) pandemic are at high risk of mental morbidity.Objectives: To assess prevalence symptoms anxiety, depression, and peritraumatic dissociation in HCPs.Methods: This was a cross-sectional study 21 ICUs France between April 20, 2020, May 21, 2020. The Hospital Anxiety Depression Scale Peritraumatic Dissociative Experience Questionnaire were used. Factors independently associated with reported health...

10.1164/rccm.202006-2568oc article EN cc-by-nc-nd American Journal of Respiratory and Critical Care Medicine 2020-08-31
Wulfran Bougouin Florence Dumas Lionel Lamhaut Éloi Marijon Pierre Carli and 95 more Alain Combes Romain Pirracchio Nadia Aïssaoui Nicole Karam Nicolas Deye Georgios Sidéris Frankie Beganton Daniel Jost Alain Cariou Xavier Jouven Frédéric Adnet Jean‐Marc Agostinucci N. Aissaoui-Balanant Vincent Algalarrondo François Alla Christine Alonso W. Amara Djillali Annane C. Antoine P Aubry Élie Azoulay Frankie Beganton D. Benhamou Clarisse Billon Wulfran Bougouin J. Boutet Cédric Bruel Patrick Bruneval Alain Cariou Pierre Carli Enrique Casalino Charles Cerf A. Chaïb Bernard Cholley Yves Cohen Alain Combes Marie Crahès D Da Silva Vijay Kumar Das Alexandre Demoule Isabelle Denjoy Nicolas Deye G. Dhonneur Jean‐Luc Diehl S. Dinanian Leszek Domański Didier Dreyfuss D Duboc J L Dubois-Randé Florence Dumas Jean‐Philippe Empana Fabrice Extramiana Muriel Fartoukh Fabienne Fieux Marco Gabbas Estelle Gandjbakhch Guillaume Géri Bertrand Guidet Franck Halimi P. Henry F. Hidden Lucet P. Jabre Line Jacob Lee Joseph Daniel Jost Xavier Jouven Nicole Karam H. Kassim Jèrôme Lacotte Khadija Lahlou‐Laforêt Lionel Lamhaut A. Lanceleur Olivier Langeron Thomas Lavergne Éric Lecarpentier Antoine Leenhardt Nicolas Lellouche Virginie Lemiale F. Lemoine F. Linval Thomas Loeb Bertrand Ludes Charles‐Édouard Luyt Alice Maltret Nicolas Mansencal Nadia Mansouri Éloi Marijon J. Marty Éric Maury Virginie Maxime Bruno Mégarbane Armand Mekontso Dessap Hervé Mentec Jean Paul Mira Xavier Monnet

Abstract Aims Out-of-hospital cardiac arrest (OHCA) without return of spontaneous circulation (ROSC) despite conventional resuscitation is common and has poor outcomes. Adding extracorporeal membrane oxygenation (ECMO) to cardiopulmonary (extracorporeal-CPR) increasingly used in an attempt improve Methods results We analysed a prospective registry 13 191 OHCAs the Paris region from May 2011 January 2018. compared survival at hospital discharge with extracorporeal-CPR identified factors...

10.1093/eurheartj/ehz753 article EN European Heart Journal 2019-10-02
Guillaume Lebreton Matthieu Schmidt Maharajah Ponnaiah Thierry Folliguet Marylou Para and 95 more Julien Guihaire Emmanuel Lansac Édouard Sage Bernard Cholley Bruno Mégarbane Pierrick Cronier Jonathan Zarka Daniel Da Silva Sébastien Besset Tristan Morichau-Beauchant Igor Lacombat Nicolas Mongardon Christian Richard Jacques Duranteau Charles Cerf Gabriel Saiydoun Romain Sonneville Jean‐Daniel Chiche Patrick Nataf Dan Longrois Alain Combes Pascal Leprince Charles Juvin Thibault Schoell Cosimo D’Alessandro Sofica Marin Nathalie Nardone Pierre Demondion Horacio MEYER Karl Bounader Alexander MOIROUX Ali Akamkam Guillaume Fadel Erwan RANDRIANALISOA Sébastien CUSQUEL Patrice LE GLOAHEC Elisabeth HIRSCHAUER Fabrice MUSQUET Pierre-Marie Jego Hélène Guedes Théophile Roy Lina Mercereau Emmanuel Corvol Anne Laboure Flore Vilanove Marco Peperoni Dariène Machado Aly Sely Marion Fortanier Séverine Gantois Émilie Tran Elisabeth Bosq Aurélie Fontanier Alice Morin Jocelyne Cousin Stéphanie Bovagnet Charles Edouard Luyt Guillaume Hékimian Nicolas Bréchot Marc Pineton de Chambrun Cyrielle Desnos Juliette Chomeloux Jérémy Arzoine Emmanuelle Guerin Antoine Monsel Guillaume Voiriot David Levy Ėlodie Baron Alexandra Beurton Juliette Chommeloux Paris Meng Safaa Nemlaghi Pierre Bay Alexandre Demoule Bertrand Guidet Jean Michel Constantin Muriel Fartoukh Martin Dres Patrick Nataf Guillaume Franchineau Lucie Le Fèvre Richard Raffoul Soleiman Alkhoder Walid Ghodbane Angelo Pisani Wael Braham A. Gara Pierre Mordant Yves-Hervé CASTIER Étienne de Montmollin Lila Bouadma Jean‐François Timsit Olivier Langeron Quentin de Roux Claire Alessandri

In the Île-de-France region (henceforth termed Greater Paris), extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) was considered early in COVID-19 pandemic. We report ECMO network organisation and outcomes during first wave of pandemic.In this multicentre cohort study, we present an analysis all adult patients with laboratory-confirmed SARS-CoV-2 infection ARDS requiring who were admitted to 17 Paris intensive care units between March 8 June 3,...

10.1016/s2213-2600(21)00096-5 article EN publisher-specific-oa The Lancet Respiratory Medicine 2021-04-20
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16
Lila Bouadma Armand Mekontso Dessap Charles Burdet Hamid Merdji Julien Poissy and 95 more Claire Dupuis Christophe Guitton Carole Schwebel Yves Cohen Cédric Bruel Mehdi Marzouk Guillaume Géri Charles Cerf Bruno Mégarbane Pierre Garçon Éric Kipnis Benoît Visseaux Naima Beldjoudi Sylvie Chevret Jean‐François Timsit Naima Beldjoudi Sylvie Chevret Charles Burdet Céline Alloux Fadila Amerali Béatrice Andriss Kamyl Baghli Hélène Brocvielle Florence Capelle Ines Chibane Sarra Dalibey Nadia Ettalhaoui Sabrine Lamri Yohan Maurer Jean-Marc Mintsa Alice Oubahim Marie-Capucine Tellier Imane Zemihi Lila Bouadma Moustafa Abdel-Nabey Billal Azzouguen Ghenima Belkessa Étienne de Montmollin Veronique Deiler Claire Dupuis Aline Fallet Guillaume Franchineau Tiphaine Girard Alexandra Grinea Pierre Jaquet Laura D. Kramer Fariza Lamara Lucie Lefèvre Mehdi Marzouk Juliette Patrier Simona Presente Faiza Sayagh Fabrice Sinnah Romain Sonneville Paul-Henri Wicky Sylia Zmihi Yves Cohen Nathalie Barget Rawan Belmokhtar Sabrina Brahmi Naoual Djabra Nathan Ebstein Souha Fliss Amina Gourbdji William Juguet Fadhila Messani Thomas Rambaud Vanessa Rathouin Mani Rebai Marthe Rigal Julien Schmidt Marie Soulié Yacine Tandjaoui-Lombiotte Anaïs Winchenne Marianne Ziol Romain Arrestier François Bagate Morgan Benais Inès Bendib LE Lan Brice Benelli Emilio Berti Astrid Bertier Guillaume Carteaux Muriel Carvalho Pedro Cavaleiro Nicolas Deprost Otto Hartman Anne-Fleur Haudebourg Delphine Le Febvre De Nailly Julien Lopinto Sabrina Mahiou Paul Masi Gaël Michaud Luiza Nait-Chabane

The benefit of high-dose dexamethasone and oxygenation strategies vs standard care for patients with severe acute hypoxemic respiratory failure (AHRF) caused by COVID-19 pneumonia is debated.To assess the compared dexamethasone, to high-flow nasal oxygen (HFNo2) or continuous positive airway pressure (CPAP) support (o2SC).This multicenter, placebo-controlled randomized clinical trial was conducted in 19 intensive units (ICUs) France from April 2020 January 2021. Eligible were consecutive...

10.1001/jamainternmed.2022.2168 article EN JAMA Internal Medicine 2022-07-05

Abstract Background Severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2)-induced distress (ARDS) causes high mortality. Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) have potentially relevant immune-modulatory properties, whose place in ARDS treatment is not established. This phase 2b trial was undertaken to assess the efficacy of UC-MSCs patients with SARS–CoV-2-induced ARDS. Methods multicentre, double-blind, randomized, placebo-controlled (STROMA–CoV-2) recruited...

10.1186/s13054-022-03930-4 article EN cc-by Critical Care 2022-02-21

<h3>Importance</h3> Persistent physical and mental disorders are frequent in survivors of COVID-19–related acute respiratory distress syndrome (ARDS). However, data on these among family members scarce. <h3>Objective</h3> To determine the association between patient hospitalization for COVID-19 ARDS vs from other causes risk posttraumatic stress disorder (PTSD)–related symptoms members. <h3>Design, Setting, Participants</h3> Prospective cohort study 23 intensive care units (ICUs) France...

10.1001/jama.2022.2017 article EN JAMA 2022-02-18
Thomas M. File Donald E. Low Paul B. Eckburg George H. Talbot H. David Friedland and 95 more Jon Lee Lily Llorens Ian A. Critchley Dirk Thye John Pullman Philip Giordano James Welker Paul Manos P. Mehra Thomas M. File Joana Espírito Santo B. Venkateswaralu C. G. Schrock William Tillis Jan A. Winetz Javier González Andrew G. Ramage Dwight D. Eisenhower Coenraad F.N. Koegelenberg Ingrid Engelbrecht Julie A. Jurgens Ismail Mitha J. Breedt Mashra Gani Jack Roos Marc D. Basson Louis van Zyl Ronel Meeding Muhammed Ameen Fulat M. Le Roux Pablo Bonvehí María Cristina Ganaha A. L. Gurini Gustavo Lopardo Laura Cristina Sergio Prieto Celestino Rodíguez Ricardo Teijeiro E Pallone Daniel Pryluka Clóvis Arns da Cunha N. B. da Silva António Freire Cláudia Starling J. Costa Fiterman Fernando Gôngora Rubio L. Carlos Losso Marco Patelli J. Souza Lima Paulo José Zimermann Teixeira Marta Moreira J. C. Abreu de Oliveira V. Roudas E. A. Gamal I. V. Leschenko В. А. Руднов A. G. Yevdokimova A. L. Vertkin Y. M. Ambalov I. V. Dvoryashina E. Zilber R. F. Khamitov A. N. Galustyan O. V. Reshetko Victoria Senior M. F. Grosan Gabriela Jimborean M. Lupse G. Aron Dan Olteanu Maria Puşchiță Claudia Gavriș V. M. Tudorache Vania Youroukova M Petkova E. Troshanova M. Dzhabalyan G Kavtaradze M. Makhviladze R. Tabukashvili Marco Pons Jorge Garbino Daniel Genné Madeleine Rothen J. O. de Saracho A. Capelastegui Rosario Menéndez Antoní Torres C. Shum Vicenç Falcó Emilio Bouza J.P. Bru Benoît Misset Bruno Mégarbane J.-P. Sollet

Ceftaroline, the active form of prodrug ceftaroline fosamil, is a novel cephalosporin with bactericidal activity against important pathogens associated community-acquired pneumonia (CAP), including Streptococcus pneumoniae and common Gram-negative pathogens. FOCUS 1 randomized, double-blinded, Phase III study that was conducted to evaluate efficacy safety fosamil in treating patients CAP. The primary objective determine non-inferiority [lower limit 95% confidence interval (CI) ≥ −10%]...

10.1093/jac/dkr096 article EN Journal of Antimicrobial Chemotherapy 2011-04-01
Coming Soon ...